Caidya’s Miles Pan Named to Legal 500 GC Powerlist China 2025
RALEIGH, N.C. and SHANGHAI, CHINA; December 19, 2025 – Caidya, a leading global contract research organization (CRO), recently announced that Miles Pan, Executive Director of Corporate Legal and China Legal Head, was named in the Legal 500 GC Powerlist: China 2025. This recognition places him among the leading general counsel and senior in-house lawyers shaping China’s corporate legal landscape.
The GC Powerlist, curated by Legal 500, is widely respected across the global legal community for identifying in-house leaders who combine legal expertise with strategic influence and organizational impact.
For Miles, this recognition reflects years of impactful work at Caidya and acknowledges his leadership at a time when clinical development, regulatory landscapes, and global investment dynamics are evolving at remarkable speed.
Miles’ contributions over the past year highlight his ability to execute complex, high-value transactions under compressed timelines. As lead in-house counsel, he oversaw Caidya’s US $165 million strategic growth equity investment from Rubicon Founders, which closed in January 2025 and was reported as the largest private-equity financing in the global clinical-CRO sector over the preceding twelve months. Delivering this transaction required him to coordinate a cross-functional team operating across multiple time zones to meet the signing and closing schedule. His leadership ensured a smooth, timely execution and demonstrated how a strategically aligned legal function can directly advance global corporate growth.
Beyond major transactions, Miles is recognized for maintaining clarity and stability during operational pressures. He leads the legal function with a calm, structured approach that ensures risks are identified early and translated into practical, business-aligned actions. His team’s “living risk playbook” offers an instant view of obligations across projects, enabling swift, legally sound decisions when unexpected challenges arise.
Chief Legal Officer David Rifkind applauded Miles most recent accomplishment: “Miles’ selection to the GC Powerlist China 2025 is more than a personal milestone for him; it perfectly reflects the strength, innovation, and forward-looking mindset we have brought to Caidya’s legal function”. Rifkind further noted: “His leadership demonstrates how modern in-house counsel can drive corporate growth, safeguard global operations, and build resilient systems that support both Caidya and the patients it serves.”
About Caidya
Caidya is a global, full-service contract research organization (CRO) built for biopharma innovators developing life-changing therapies. Conducting studies in over 50 countries and a strong presence across North America, Europe, and Asia-Pacific, Caidya delivers a superior customer experience through personalized solutions that span the full clinical development lifecycle. From pre-IND strategy through study closeout and post-marketing, Caidya brings therapeutic expertise, operational agility, and an ownership mindset to every partnership. Specializing in complex, multi-regional trials across oncology and hematology, rare disease, pediatrics, dermatology, nephrology, cell and gene therapy, cardiovascular, and more, Caidya consistently delivers on timelines and outcomes. Working shoulder to shoulder as partners, Caidya brings expertise relevant to sponsors’ studies, agility to navigate complex trials, and global access to patients, yielding the high-quality data sponsors need to make informed decisions – for today, and tomorrow.
MEDIA CONTACT:
Roger Boutin
VP, Corporate Marketing, Caidya